FDA Drug Shortage Database
Hydralazine (Apresoline) shortage
No hydralazine presentation is listed as limited or unavailable in the FDA Drug Shortage Database (read October 8, 2026); it keeps 1 current entry listed as available (updated August 27, 2026). ASHP keeps a separate shortage list, which can differ.
- Generic listed
Check it at the source: the FDA Drug Shortage Database.
Which strengths are short?
| Strength | Limited or unavailable now | Listed now, available | Resolved or discontinued |
|---|---|---|---|
| 10mg/ml injection | 0 | 1 | 0 |
Which presentations are listed?
Listed now, available (1)
| Presentation | Company | Status and dates | Availability and reason given |
|---|---|---|---|
| Furosemide, Injection, 10 mg/mL, 2 mL (NDC 71288-205-03) | Meitheal Pharmaceuticals, Inc. | Current posted April 7, 2020, updated August 27, 2026 | Available |
Source: FDA Drug Shortage Database via openFDA, read October 8, 2026
What next?
- Every shortage now
- medicines by presentations in shortage